Navigation Links
NUCRYST Announces Distribution of Supplemental Information In Connection with Special Meeting of Shareholders
Date:1/15/2010

y change their vote prior to the reconvened meeting by following the instructions provided in the Supplement. For those shareholders who have previously voted in respect of the Amalgamation Resolution and do not wish to change their vote, no action is required. Under the Amalgamation as proposed, Nucryst shareholders other than Westaim will receive for each issued and outstanding share in Nucryst one redeemable preferred share in the capital of Amalco, which will be redeemed for US$1.77 in cash upon the completion of the Amalgamation. If the Amalgamation is ultimately approved by shareholders and completed, Nucryst intends to delist from the TSX and NASDAQ stock exchanges.

This news release is for information purposes only and is not a substitute for the definitive agreements or other disclosures provided in the Information Circular, Supplement and previous supplements provided to shareholders in relation to the Amalgamation. There can be no assurance that the closing conditions of the Amalgamation will be satisfied, or that the transaction will be completed as proposed or at all.

About NUCRYST Pharmaceuticals Corp.

NUCRYST Pharmaceuticals Corp. (NASDAQ: NCST; TSX: NCS) sold its Acticoat business, constituting substantially all of its assets, on December 22, 2009. The Company now consists primarily of cash and short-term investments and no longer has any operating income. The Company retains a few employees who are working towards the completion of the proposed Amalgamation.

This news release contains forward-looking statements within the meaning of securities legislation in the United States and Canada (collectively "forward-looking statements"). Forward-looking statements in thi
'/>"/>

SOURCE NUCRYST Pharmaceuticals Corp.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine news :

1. NUCRYST and Smith & Nephew Revise Agreements
2. Webcast Advisory - NUCRYST Pharmaceuticals Webcast of Conference Call to Discuss 2007 Third Quarter Results
3. NUCRYST Pharmaceuticals announces 2007 third quarter results
4. NUCRYST Pharmaceuticals announces year-end results
5. NUCRYST Announces Senior Management Change
6. NUCRYST Announces Management Realignment and R&D Portfolio Change
7. NUCRYST Announces First Quarter 2008 Financial Results
8. NUCRYST Appoints David B. Holtz as Vice President and Chief Financial Officer
9. NUCRYST Pharmaceuticals to Release Second Quarter 2008 Financial Results on Tuesday, August 12, 2008
10. NUCRYST Receives Deficiency Notice from NASDAQ
11. The Westaim Corporation requisitions meeting of shareholders of NUCRYST Pharmaceuticals to return capital to NUCRYST shareholders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/2/2015)... (PRWEB) March 02, 2015 Robins & ... In conjunction with Women in Construction Week (March 1-7, ... or NAWIC) and National Women’s History Month, Robins & ... positively affect the company and the construction industry as ... team, to the dozens of roles in between, each ...
(Date:3/2/2015)... (PRWEB) March 02, 2015 The Workgroup ... authority on the use of health IT to create ... paper, “ICD-10 Testing for Small Providers.” The white paper ... a starting point for ICD-10 testing by focusing on ... to ensure compliance with the October 1, 2015 implementation ...
(Date:3/2/2015)... This year, the National Multiple Sclerosis Society’s annual ... for people across the country to unite, raise awareness, ... live their best lives. MS Awareness Week is a special ... join the Society’s vision of a world free of MS. ... of the central nervous system, interrupts the flow of information ...
(Date:3/2/2015)... Four Seasons Resort Maui at Wailea, the ... this year, having officially opened its doors on March 2, ... honoring over 70 employees who started on Day 1 and ... approximately 400 original employees. The celebration will be a ... , This Four Seasons flagship resort, the first resort ...
(Date:3/2/2015)... 2015 What are the best practices ... references? When are interviews scheduled, how can physicians best ... training and practicing physicians who are looking for new ... more at the PracticeLink Physician Career Advancement Workshop and ... Fair is from 5:30 to 8:30 p.m. at the ...
Breaking Medicine News(10 mins):Health News:Robins & Morton Recognizes Women In Construction 2Health News:WEDI Releases New White Paper on ICD-10 Testing for Small Providers 2Health News:Every Connection Counts During MS Awareness Week 2Health News:Every Connection Counts During MS Awareness Week 3Health News:Every Connection Counts During MS Awareness Week 4Health News:Celebrating Four Seasons Resort Maui’s 25th Anniversary 2Health News:PracticeLink to Host a Career Advancement Workshop and Job Fair in Houston 2
... proof cancer will spread to the healthy second ... -- Women diagnosed with breast cancer who have a ... breast removed as a preventive measure. , The rate ... than doubled from 1998 to 2003, according to a ...
... JOSE, Calif., Oct. 22 The start of the,patent ... ) against,three endovenous laser competitors, Diomed, AngioDynamics and Vascular,Solutions, ... of,October 29. The delay is due to a busy ... to identify potential new trial start dates. At,the conference, ...
... Dialysis Corporation,of America (Nasdaq: DCAI ) ... 2007 earnings after the close of the markets ... America owns and operates freestanding kidney,hemodialysis centers located ... and Virginia, and provides in-hospital,dialysis services on a ...
... to Act in Good Faith with Employees, Leads,District ... The American Federation,of Government Employees (AFGE), which represents ... Health System (NF/SGVHS), today,criticized the Department of Veterans ... with its employees by failing to honor the ...
... Oct. 22 AtriCure, Inc.,(Nasdaq: ATRC ), a ... cardiac surgical devices, will release,its financial results for the ... AtriCure will host a conference call at 10:00 ... quarter 2007 results. A live web cast of,the conference ...
... Cereal cuts cardiovascular risk, as do fruits, veggies, research ... rich in whole grains, fruits, vegetables and even a ... studies show. , In one study, regular consumption of ... for male American physicians. , Another study, this time ...
Cached Medicine News:Health News:More Women Choosing 'Preventive' Double Mastectomy 2Health News:More Women Choosing 'Preventive' Double Mastectomy 3Health News:Delay in Start of VNUS Patent Litigation and Court Ruling on Summary Judgment Motion 2Health News:Dialysis Corporation of America Announces Third Quarter 2007 Earnings Release Date 2Health News:Mismanagement at North Florida/South Georgia Veterans Health System Results in Chronic Staff Shortages, Budget Issues 2Health News:AtriCure Announces Web Cast and Conference Call of Third Quarter 2007 Financial Results 2Health News:Whole Grains Do a Heart Good 2Health News:Whole Grains Do a Heart Good 3
(Date:3/2/2015)...  Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD ) ... and commercialization of a once-daily, oral therapy for the ... that Josh Blacher , Chief Financial Officer, will ... conference in Laguna Niguel, California ... Standard Time. A live webcast of the presentation will ...
(Date:3/2/2015)...  SI-BONE, Inc., a medical device company that pioneered ... the sacroiliac (SI) joint with the iFuse Implant System ... have now been performed world wide utilizing more than ... iFuse procedure continues to grow and gain momentum with ... the United States and 17 countries ...
(Date:3/2/2015)... N.J. and BETHESDA, Md. ... development-stage immunotherapy company focused on treating and preventing autoimmune ... 2-stage, anti-IL-15 monoclonal antibody (AMG 714) from Amgen (NASDAQ: ... exclusive license agreement, Celimmune has the rights to develop, ... excluding Japan . Concurrently, Amgen has ...
Breaking Medicine Technology:Galmed Pharmaceuticals to Present at the 27th Annual ROTH Conference 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 2SI-BONE, Inc. Announces 15,000 iFuse Procedure Milestone 3Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 2Celimmune Announces Anti-IL-15 Antibody Licensing and Option Agreements with Amgen 3
The Easy Wrap Apron is now available with an attached Thyroid Collar. The Thyroid Collar is held on with velcro so it adjusts to fully protect the neck. This Apron with Collar is available in 5mm lea...
... knee system is a long ... a clinically proven design. Available ... anatomically correct cruciate retaining configurations. ... ease of identification keeps the ...
... The Genesis II® Total Knee System will ... far more is possible with less - ... while fully addressing both clinical and cost ... these design goals, giving surgeons creative solutions ...
Cementless hip system...
Medicine Products: